Pancoast tumors (superior sulcus tumors) are apical lung cancers that may cause any or all of the symptoms originally described in 1932 as Pancoast's syndrome. We have presented a case report and a review of pertinent literature on the treatment of this tumor. Our patient was treated with preoperative radiation and en bloc tumor resection, the current standard of care for cure of Pancoast tumor. We support an aggressive approach in the treatment of this tumor, as radiation followed by radical tumor resection offers good palliation and the best chance for cure. Magnetic resonance imaging has emerged as the procedure of choice to assess the local extent of tumor, and in our patient, MRI accurately predicted that the tumor was resectable.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00007611-199212000-00027 | DOI Listing |
Cureus
December 2024
Pathology and Laboratory Medicine, Arrowhead Regional Medical Center, Colton, USA.
Thoracic SMARCA4-deficient undifferentiated tumor (TSDUT) is a rare and quite new classification of primary pulmonary malignancy. It is classified as a non-small cell lung cancer, typically associated with smoking, and is highly aggressive. Its clinical features, immunohistochemistry, and pathology are quite unique.
View Article and Find Full Text PDFPort J Card Thorac Vasc Surg
October 2024
Thoracic Surgery Department - Hospital de Santa Marta, Centro Hospitalar Universitário Lisboa Central, Portugal.
Introduction: Pancoast tumors encompass any tumor located on the lung apex, extending into structures in the thoracic inlet and, often, leading to the characteristic clinical syndrome. The main goal of this study is to analyze the response to multimodal treatment and outcome of patients with Pancoast tumors.
Materials And Methods: We performed a retrospective cohort single center study of patients with superior sulcus nonsmall cell lung carcinomas who underwent surgery between January of 2011 and February of 2022.
J Clin Med
December 2024
Department of Radiotherapy and Radiation Oncology, Faculty of Medicine, University of Augsburg, 86156 Augsburg, Germany.
: To analyze the results of interstitial (IRT) high-dose-rate (HDR) brachytherapy (BT) in the primary treatment of patients with unresectable superior sulcus tumors (SST) combined with external beam radiotherapy (EBRT). : Between 2013 and 2023, seven patients with unresectable SST were treated with combined BT and EBRT with or without concomitant chemotherapy. The patients' median age was 64 years (range, 49-79 years) and median tumor volume was 146.
View Article and Find Full Text PDFAME Case Rep
August 2024
Department of Anesthesiology and Pain Medicine, Juntendo University Hospital, Tokyo, Japan.
JACC Case Rep
August 2024
Department of Diagnostic and Interventional Imaging, University of Texas Health Science Center at Houston, Houston Texas, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!